Edition:
United States

Baxter International Inc (BAX)

BAX on New York Consolidated

58.59USD
26 May 2017
Change (% chg)

$-0.55 (-0.94%)
Prev Close
$59.14
Open
$59.07
Day's High
$59.11
Day's Low
$58.45
Volume
1,296,723
Avg. Vol
2,946,018
52-wk High
$59.41
52-wk Low
$42.22

BAX

Chart for BAX

About

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled... (more)

Overall

Beta: 0.69
Market Cap(Mil.): $32,152.59
Shares Outstanding(Mil.): 543.67
Dividend: 0.16
Yield (%): 1.08

Financials

  BAX Industry Sector
P/E (TTM): 17.62 31.23 17.43
EPS (TTM): 3.36 -- --
ROI: 13.84 12.80 -5.41
ROE: 20.92 15.29 -4.69

BRIEF-Third Point LLC dissolves share stake in Apple, Goldman Sachs

* Third Point LLC dissolves share stake in Apple Inc - sec filing

May 12 2017

BRIEF-Baxter International says in April became aware of criminal investigation by antitrust division of DOJ- SEC filing

* in April 2017, co became aware of criminal investigation by U.S. DOJ, antitrust division and federal jury in U.S. District court for eastern district of Pennsylvania-filing

May 04 2017

BRIEF-Baxter International says received guidance from FDA clarifying regulatory pathway for new peritoneal dialysis technology

* Baxter International Inc - received guidance from FDA clarifying regulatory pathway for new peritoneal dialysis technology

May 03 2017

BRIEF-Baxter raises quarterly dividend

* Baxter International Inc - sets qtrly dividend of 13 cents per share Source text for Eikon: Further company coverage:

May 02 2017

BRIEF-Baxter International Q1 revenue $2.5 billion

* Baxter reports first-quarter 2017 results and increases financial outlook for full-year 2017

Apr 26 2017

BRIEF-Walgreens Boots Alliance elects Baxter International CEO José Almeida to its board

* José E. Almeida, chairman and ceo of Baxter International, elected to Walgreens Boots Alliance board of directors

Apr 19 2017

BRIEF-Baxter CEO José Almeida's FY 2016 compensation $5.8 mln vs $7.95 mln in FY 2015

* Ceo josé almeida's fy 2016 total compensation $5.8 million versus $7.95 million in fy 2015 - sec filing Source text for Eikon: Further company coverage:

Mar 17 2017

BRIEF-Ameren CEO Warner L. Baxter's 2016 compensation $6.6 mln vs $6.5 mln in 2015

* Ameren corp- ceo warner l. Baxter's total 2016 compensation was $6.6 million versus $6.5 million in 2015 Source text for Eikon: Further company coverage:

Mar 15 2017

U.S. medtech shares gain as investors seek shelter from drug price debate

NEW YORK Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that President Donald Trump's criticism of drug prices makes owning pharmaceutical and biotechnology stocks risky.

Mar 13 2017

U.S. medtech shares gain as investors seek shelter from drug price debate

NEW YORK, March 13 Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that U.S. President Donald Trump's criticism of drug prices makes owning pharmaceutical and biotechnology stocks risky.

Mar 13 2017

More From Around the Web

Earnings vs. Estimates